Literature DB >> 18342717

Abortive or minimal-growth hemangiomas: Immunohistochemical evidence that they represent true infantile hemangiomas.

Francisca Corella1, Xavier Garcia-Navarro, Adriana Ribe, Agustin Alomar, Eulalia Baselga.   

Abstract

BACKGROUND: Infantile hemangiomas have a characteristic natural history of rapid proliferation in the first weeks of life followed by spontaneous involution. At birth, they may be present as a precursor lesion. Sometimes one may see precursor lesions that never undergo a growth phase or that undergo minimal growth. It is unclear the exact nature of these precursor-like lesions.
OBJECTIVE: We sought to describe the morphology and histopathology of these precursor-like lesions.
METHODS: We describe 4 patients with macules resembling precursor lesions of hemangiomas that did not show proliferation phase or minimal growth. The histopathologic and immunohistochemical study with glucose transporter-1 was performed in all of these cases.
RESULTS: The skin biopsy specimen showed superficial ectatic vessels that reacted with anti-glucose transporter-1 antibodies. All skin biopsy specimens exhibited capillary lobules in papillary dermis and, in two of them, in the reticular dermis and subcutis. LIMITATIONS: This text is limited by the number of cases reported.
CONCLUSIONS: Precursor lesions of hemangioma that do not show proliferation phase or minimal growth represent, in the view of glucose transporter-1 immunoreactivity, true hemangiomas of infancy with an aborted or arrested growth cycle.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18342717     DOI: 10.1016/j.jaad.2007.08.007

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

1.  A potential role for notch signaling in the pathogenesis and regulation of hemangiomas.

Authors:  June K Wu; Jan K Kitajewski
Journal:  J Craniofac Surg       Date:  2009-03       Impact factor: 1.046

2.  Prospective study of infantile haemangiomas: incidence, clinical characteristics and association with placental anomalies.

Authors:  A Munden; R Butschek; W L Tom; J S Marshall; D M Poeltler; S E Krohne; A B Alió; M Ritter; D F Friedlander; V Catanzarite; A Mendoza; L Smith; M Friedlander; S F Friedlander
Journal:  Br J Dermatol       Date:  2014-04       Impact factor: 9.302

3.  Different Clinical Features of Acral Abortive Hemangiomas.

Authors:  N Vega Mata; J C López Gutiérrez; B Vivanco Allende; M S Fernández García
Journal:  Case Rep Dermatol Med       Date:  2017-07-12

4.  Infantile Hemangiomas with Minimal and Arrested Growth: Clinical Features and Treatment Outcomes with 0.5% Topical Timolol Maleate.

Authors:  Kyung-Nam Bae; Kihyuk Shin; Hoon-Soo Kim; Byung-Soo Kim; Moon-Bum Kim; Hyun-Chang Ko
Journal:  Ann Dermatol       Date:  2021-09-08       Impact factor: 1.444

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.